These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6214404)

  • 1. Suppressor T cells and the regression phase of syngeneic intradermally developing p-815 mastocytomas.
    Bertschmann M; Schären B; Lüscher EF
    Eur J Cancer Clin Oncol; 1982 Apr; 18(4):405-11. PubMed ID: 6214404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells.
    Maier T; Levy JG; Kilburn DG
    Cell Immunol; 1980 Dec; 56(2):392-9. PubMed ID: 6451300
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
    Awwad M; North RJ
    Cancer Res; 1989 Apr; 49(7):1649-54. PubMed ID: 2522344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES; North RJ
    J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse.
    Bertschmann M; Schären B; Lüscher EF
    Immunobiology; 1980 Jan; 156(4-5):382-99. PubMed ID: 6768671
    [No Abstract]   [Full Text] [Related]  

  • 8. The inability of adoptive immunotherapy to eradicate tumor cells in radiation-induced chimeric mice: the possible down-regulation of intratumor immune amplification.
    Evans R; Duffy TM
    Int J Cancer; 1987 Feb; 39(2):226-31. PubMed ID: 2948923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    Mills CD; North RJ
    J Exp Med; 1983 May; 157(5):1448-60. PubMed ID: 6189937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
    Awwad M; North RJ
    J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive immunotherapy is suppressed in C57BL/6J and B6.C-H-2bm12 mice following recognition of congenic class II MHC antigen determinants.
    Evans R; Duffy TM
    Int J Cancer; 1989 Nov; 44(5):854-8. PubMed ID: 2479606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of specific suppressor cells with heat-treated allogeneic tumor cells.
    Chiu KM; Faanes RB; Choi YS
    Cell Immunol; 1980 Feb; 49(2):283-92. PubMed ID: 6444368
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.
    Dye ES; North RJ
    Transplantation; 1984 Jun; 37(6):600-5. PubMed ID: 6427998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination.
    Andrade-Mena CE
    Int J Tissue React; 1994; 16(2):95-103. PubMed ID: 7960506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
    North RJ
    J Exp Med; 1982 Apr; 155(4):1063-74. PubMed ID: 6460831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
    Leshem B; Kedar E
    J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor.
    Maier T; Levy JG
    Cancer Immunol Immunother; 1982; 13(2):134-9. PubMed ID: 6819080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of suppressor cells by syngeneic tumor transplants in mice.
    Argyris BF
    Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive growth of immunogenic tumors: relationship between susceptibility of ascites P815 tumor cells to T-cell-mediated lysis and immune destruction in vivo.
    Fahey JR; Hines DL
    Cancer Res; 1987 Sep; 47(18):4759-65. PubMed ID: 3113723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.